Human Alpha 1 Acid Glycoprotein (A1AGP)
Native whole molecule
Produktdetails
Synonyms
A1AGP, AGP, AAG, Orosomucoid, ORM
Description of Human Alpha 1 Acid Glycoprotein (A1AGP)
Human Alpha 1 Acid Glycoprotein (A1AGP) is a ~45000 Da under Reducing and Non-Reducing Conditions by SDS-PAGE protein. Alpha-1 acid glycoprotein (AGP), a glycoprotein constituting 55–140 mg/dL of plasma, features five N-linked glycan chains comprising 40–45% of its mass, including sialylated bi-/tri-/tetra-antennary structures critical for ligand interactions. Thus contributing to its use as a standard for glycosylation studies. As a major acute-phase reactant, AGP surges up to 5-fold during inflammation, synergizing with haptoglobin to diagnose acute inflammation and differentiate hepatic vs. obstructive jaundice. Its glycosylation profile shifts in pathologies: acute inflammation increases bi-antennary and α1, 3-fucosylated glycans, while chronic states enhance tri-/tetra-antennary fucosylation. AGP binds progesterone 15× more avidly than albumin and complexes with vitamin B-12 when sialic acid-deficient, influencing drug pharmacokinetics and nutrient transport. AGP modulates immunity via TLR-2/4 interactions, exacerbating TLR-2-mediated sepsis mortality while inhibiting LPS-driven NETosis. Dysregulated AGP correlates with rheumatoid arthritis, Waldenström macroglobulinemia, and metastatic cancers, where glycoforms alter platelet aggregation and neutrophil adhesion. The AGP:haptoglobin ratio aids in diagnosing bone marrow disorders and hemolytic anemia, reflecting erythropoietic activityTherapeutically, AGP’s drug-binding capacity informs personalized dosing for basic drugs (e.g., chlorpromazine), while engineered glycoforms are explored for targeted anti-inflammatory therapies.
Source
Human plasma non-reactive for HBsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests
Storage
For long term, store Human Alpha 1 Acid Glycoprotein (A1AGP) at ≤ -20°C.
Applications
Protein Glycosylation studies, In Vitro Diagnostics, Antisera Production.
Citations/Publications
Decurtins, W., et al., (2018) 'Automated screening for small organic ligands using DNA-encoded chemical libraries', Nature Protocols, 11: pp 764–780 (2016). Available at doi:10.1038/nprot.2016.039
Zhong, C., et al., (2018) 'Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species', Acta Pharmacologica Sinica, 39: pp 1048–1063. Available at doi: 10.1038/aps.2017.199
Zhang, N., et al., (2018) 'Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management', Drug Metab Dispos 46: pp 823–834. Available at https://doi.org/10.1124/dmd.117.079673
van Schaick, G., et al., (2024) 'Anion Exchange Chromatography–Mass Spectrometry to Characterize Proteoforms of Alpha-1-Acid Glycoprotein during and after Pregnancy', Journal of Proteome Research, 23(7): pp 2431-2440. Available at DOI: 10.1021/acs.jproteome.4c00107
NCBI: https://www.ncbi.nlm.nih.gov/protein/P02763/
Shipped with ice packs
Gel Scan of Human Alpha 1 Acid Glycoprotein (A1AGP)
Fig. 1: SDS-PAGE Gel |
Usage: For research use only. Not for use in diagnostic or therapeutic procedures. Not for human use.
To buy Human Alpha 1 Acid Glycoprotein (A1AGP) please click on the Shopping List Symbol right from the indicated price. This will add Human Alpha 1 Acid Glycoprotein (A1AGP) to your Shopping List. You can then click on the button »Shopping List & Order Form« to ask for a quote. We will send you your quote as soon as possible. Our offer will include institutional discounts where applicable.
For business customers only. All prices are net prices (excluding VAT). Final prices in our quote will contain VAT plus shipping costs if applicable. For further information please go to our Shipping page.
Errors, changes and availability excepted.


Payment Methods
Paying by bank transfer
